Ecteinascidin 743 in Treating Patients With Malignant Mesothelioma
Status:
Terminated
Trial end date:
2002-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of ecteinascidin 743 in treating patients
who have malignant mesothelioma that cannot be removed by surgery.